DUBLIN--(BUSINESS WIRE)--The "Kaposi's Sarcoma - Pipeline Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.
Scope
- The report provides a snapshot of the pipeline development for Kaposi's Sarcoma
- The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for Kaposi's Sarcoma
- The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Kaposi's Sarcoma
- The report also covers the dormant and discontinued pipeline projects related to Kaposi's Sarcoma
- Aphios Corp.
- Cannabis Science Inc.
- CytRx Corp.
- LATITUDE Pharmaceuticals Inc.
- RedHill Biopharma Ltd.
- Tumorend LLC
- VasGene Therapeutics Inc.
Key Topics Covered
1. Report Introduction
2. Kaposi's Sarcoma Overview
3. Pipeline Therapeutics
- An Overview of Pipeline Products for Kaposi's Sarcoma
4. Comparative Analysis
5. Products in Clinical Stage
5.1 Drug Name: Company Name
- Product Description
- Research and Development
- Product Development Activities
6. Products in Pre-Clinical and Discovery Stage
6.1 Drug Name: Company Name
- Product Description
- Research and Development
- Product Development Activities
7. Therapeutic Assessment
- Assessment by Route of Administration
- Assessment by Stage and Route of Administration
- Assessment by Molecule Type
- Assessment by Stage and Molecule Type
8. Inactive Products
8.1 Drug Name: Company Name
- Product Description
- Research and Development
- Product Development Activities
For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/hqsqgl/kaposis_sarcoma?w=4